Trulieve Cannabis (TCNNF) director Thad Beshears won’t seek reelection at June 2026 meeting
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Trulieve Cannabis Corp. reported that director Thad Beshears has notified the company he will not stand for reelection to the board at the annual meeting of shareholders scheduled for June 9, 2026. Beshears has served as a director since 2015, and his decision is stated to be not due to any disagreement with the company regarding its operations, policies, or practices.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Annual meeting date: June 9, 2026
Director service start year: 2015
2 metrics
Annual meeting date
June 9, 2026
Date of shareholders’ meeting where Beshears will not stand for reelection
Director service start year
2015
Year Thad Beshears became a director of Trulieve Cannabis Corp.
Key Terms
Emerging Growth Company, annual meeting of the shareholders, board of directors, Securities Exchange Act of 1934
4 terms
Emerging Growth Company regulatory
"Emerging Growth Company o o Item 5.02 Departure of Directors"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
board of directors financial
"will not be standing for reelection to the board of directors at the annual meeting"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
Securities Exchange Act of 1934 regulatory
"Pursuant to the requirements of the Securities Exchange Act of 1934, as amended"
FAQ
What did Trulieve Cannabis Corp. (TCNNF) disclose about its board in this 8-K?
Trulieve Cannabis Corp. disclosed that director Thad Beshears will not stand for reelection at the June 9, 2026 annual shareholder meeting. The company stated his decision is not due to any disagreement over operations, policies, or practices, indicating a routine board transition.
Why is director Thad Beshears leaving the Trulieve Cannabis Corp. (TCNNF) board?
Thad Beshears informed Trulieve Cannabis Corp. that he will not stand for reelection to the board at the June 9, 2026 annual meeting. The company specifically states his decision is not due to any disagreement regarding operations, policies, or practices at Trulieve.
How long has Thad Beshears served on the Trulieve Cannabis Corp. (TCNNF) board?
Thad Beshears has served as a director of Trulieve Cannabis Corp. since 2015. His decision not to stand for reelection at the June 9, 2026 annual shareholder meeting ends a multi-year tenure on the company’s board, according to the current report disclosure.
Does Trulieve Cannabis Corp. (TCNNF) report any disagreement with Thad Beshears?
No. Trulieve Cannabis Corp. states that Thad Beshears’ decision not to stand for reelection to the board was not due to any disagreement with the company. This includes matters related to its operations, policies, or practices, suggesting an orderly and non-contentious transition.
Which Trulieve Cannabis Corp. (TCNNF) officer signed this 8-K filing?
The report was signed on behalf of Trulieve Cannabis Corp. by Eric Powers, the company’s Chief Legal Officer. His signature indicates he is the duly authorized officer executing the filing under the requirements of the Securities Exchange Act of 1934, as amended.